These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12137685)

  • 21. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Graft type for femoro-popliteal bypass surgery.
    Mamode N; Scott RN
    Cochrane Database Syst Rev; 2000; (2):CD001487. PubMed ID: 10796649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of hypertension in peripheral arterial disease.
    Lip GY; Makin AJ
    Cochrane Database Syst Rev; 2003; (4):CD003075. PubMed ID: 14583959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperhomocysteinemia: marker of systemic atherosclerosis in peripheral arterial disease.
    Taute BM; Taute R; Heins S; Behrmann C; Podhaisky H
    Int Angiol; 2004 Mar; 23(1):35-40. PubMed ID: 15156128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homocysteine: a new risk factor for atherosclerosis.
    Fallest-Strobl PC; Koch DD; Stein JH; McBride PE
    Am Fam Physician; 1997 Oct; 56(6):1607-12, 1615-6. PubMed ID: 9351429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cilostazol for peripheral arterial disease.
    Robless P; Mikhailidis DP; Stansby GP
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003748. PubMed ID: 17253494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Garlic for peripheral arterial occlusive disease.
    Jepson RG; Kleijnen J; Leng GC
    Cochrane Database Syst Rev; 2000; (2):CD000095. PubMed ID: 10796487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial.
    Vermeulen EG; Stehouwer CD; Valk J; van der Knaap M; van den Berg M; Twisk JW; Prevoo W; Rauwerda JA
    Eur J Clin Invest; 2004 Apr; 34(4):256-61. PubMed ID: 15086356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people.
    Malouf R; Grimley Evans J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004514. PubMed ID: 18843658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homocysteine and occlusive arterial disease.
    O'Grady H; Kelly C; Bouchier-Hayes D; Leahy A
    Br J Surg; 2002 Jul; 89(7):838-44. PubMed ID: 12081732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventions for fatigue in peripheral neuropathy.
    White CM; van Doorn PA; Garssen MP; Stockley RC
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD008146. PubMed ID: 25519471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.
    Dörffler-Melly J; Koopman MM; Prins MH; Büller HR
    Cochrane Database Syst Rev; 2005 Jan; (1):CD002071. PubMed ID: 15674891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artichoke leaf extract for treating hypercholesterolaemia.
    Pittler MH; Thompson CO; Ernst E
    Cochrane Database Syst Rev; 2002; (3):CD003335. PubMed ID: 12137691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Herbal and dietary therapies for primary and secondary dysmenorrhoea.
    Proctor ML; Murphy PA
    Cochrane Database Syst Rev; 2001; (3):CD002124. PubMed ID: 11687013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts.
    Da Silva AF; Escofet X; Rutherford PA
    Cochrane Database Syst Rev; 2003; (2):CD002786. PubMed ID: 12804437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical versus conservative treatment for acute injuries of the lateral ligament complex of the ankle in adults.
    Kerkhoffs GM; Handoll HH; de Bie R; Rowe BH; Struijs PA
    Cochrane Database Syst Rev; 2002; (3):CD000380. PubMed ID: 12137612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitazoxanide for chronic hepatitis C.
    Nikolova K; Gluud C; Grevstad B; Jakobsen JC
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD009182. PubMed ID: 24706397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventions for treating femoral shaft fractures in children and adolescents.
    Madhuri V; Dutt V; Gahukamble AD; Tharyan P
    Evid Based Child Health; 2014 Dec; 9(4):753-826. PubMed ID: 25504970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homocysteine: an independent risk factor for the failure of vascular intervention.
    Currie IC; Wilson YG; Scott J; Day A; Stansbie D; Baird RN; Lamont PM; Tennant WG
    Br J Surg; 1996 Sep; 83(9):1238-41. PubMed ID: 8983615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.